Our results support these findings, as patients with SAE exhibited significantly higher IL-6 levels than the non-SAE group, suggesting that IL-6 may serve as a valuable marker for assessing the severity of neurological impairment in sepsis. The gene discussed is IL6; the disease is Sepsis.